Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?

Journal of the American College of Cardiology

Volumn 28, Issue 2, 1996, Pages 345-353

  Mickelson, Judith K ^a,b   Lakkis, Nasser M ^a   Villarreal Levy, Gerardo ^a,b   Hughes, Bonnie J ^b   Smith, C Wayne ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD11B ANTIGEN; HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE ADHESION;

EID: 0030221129     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00164-7     Document Type: Article

References (60)

1. 1. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-73.
2. 2. Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-91.
3. 3. Ross R, Faggiotto A, Bowen-Pope D, Raines E. The role of endothelial injury and platelet and macrophage interactions in atherosclerosis. Circulation 1984;70 Suppl III:III-77-82.
4. 4. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-44.
5. 5. McMurray HF, Parthesarathey S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest 1993;92:1004-8.
6. 6. Mazzone A, De Servi S, Ricevuti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:358-63.
7. 7. Serneri GGN, Abbate R, Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86: 790-7.
8. 8. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991;84:1758-72.
9. 9. Sheridan FM, Dauber IM, McMurtry IF, Lesnefsky EJ, Horwitz LD. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res 1991;69:1566-74.
10. 10. Entman ML, Ballantyne CM. Inflammation in acute coronary syndromes [Editorial]. Circulation 1993;88:800-3.
11. 11. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
12. 12. Schaer GL, Hursey TL, Abrahams L, et al. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (Poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation 1994;20: 2964-75.
13. 13. Deng MC, Bell S, Huie P, et al. Cardiac allograft vascular disease: relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. Circulation 1995;91:1647-54.
14. 14. DeServi S, Mazzone A, Ricevuti G, et al. Granulocyte activation after coronary angioplasty in humans. Circulation 1990;82:140-6.
15. 15. Ikeda H, Nakayama H, Oda T. et al. Neutrophil activation after percutaneous transluminal coronary angioplasty. Am Heart J 1994;128:1091-8.
16. 16. Hughes BJ, Hollers JC, Crockett-Torabi E, Smith CW. Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 1992;90:1687-96.
17. 17. Willerson JT, Hillis LD, Winniford M, Buja LM. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol 1986;8:245-50.
18. 18. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986;73:418-27.
19. 19. Falk E. Unstable angina with fatal outcome; dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985;71:699-708.
20. 20. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden death. N Engl J Med 1987;316:1514-8.
21. 21. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;296:320-31.
22. 22. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to platelet Gp1b initiates signals for platelet activation. J Clin Invest 1991;88:1568-73.
23. 23. Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991;65:467-73.
24. 24. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848-51.
25. 25. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78: 1760-9.
26. 26. Marmur JD, Merlini PA, Sharma SK, et al. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol 1994;24:1484-91.
27. 27. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730-7.
28. 28. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70.
29. 29. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79:1201-5.
30. 30. Rinder CS, Gaal D, Student LA, Smith BR. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:280-8.
31. 31. Evangelista V, Piccardoni P, Maugeri N, De Gaetano G, Cerletti C. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G. Eur J Pharmacol 1992;216:401-5.
32. 32. Bazzoni G, Nunez AB, Mascellani G, Bianchini P, Dejana E, del Maschio A. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med 1993;121:268-75.
33. 33. Feldman LJ, Chollet-Martin S, Himbert D, et al. Modulation of the expression of the granulocyte adhesion molecule, CR3, by percutaneous transluminal coronary angioplasty and contrast media. Invest Radiol 1994; 29:313-8.
34. 34. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation 1993;88:1310-23.
35. 35. Holmes DJ, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984;53:77c-81c.
36. 36. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758-69.
37. 37. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet." Am Heart J 1991;122:171-87.
38. 38. Topol EJ, Califf RM, Weisman HF, et al. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.
39. 39. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 1992;86 Suppl III:III-47-52.
40. 40. Epstein SE, Speir E, Unger EF, Guzman RJ, Finkel T. The basis of molecular strategies for treating coronary restenosis after angioplasty. J Am Coll Cardiol 1994;23:1278-88.
41. 41. Pietersma A, Kofflard M, DeWit EA, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995;91:1320-5.
42. 42. Kuijpers TW, Hoogerwerf M, van der Laan LJ, et al. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol 1992;118:457-66.
43. 43. Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell 1991;66:921-33.
44. 44. Smith CW, Kishimoto TK, Abbass O, et al. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 1991;87:609-18.
45. 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol 1992;263 Heart Circ Physiol 32:H1034-44.
46. 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol 1992;263 Heart Circ Physiol 32:H1034-44.
47. 46. Altieri DC. Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion. Blood 1993;81:569-79.
48. 47. Marcus AJ. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood 1990;76:1903-7.
49. 48. van der Wal AC, Becker AE, van der Los CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
50. 49. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atheroslcerotic plaque. Proc Natl Acad Sci U S A 1989;86:2839-43.
51. 50. Valente AJ, Rozek MM, Sprague EA, Schwartz CJ. Mechanisms in intimal monocyte-macrophage recruitment: a special role for monocyte chemotactic protein-1. Circulation 1992;86 Suppl III:III-20-25.
52. 51. Jude B, Agraou B, McFadden EP, et al. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994;90: 1662-8.
53. 52. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994;8:385-90.
54. 53. Kapplemayer J, Bernabei A, Edmunds LH, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 1993;72:1075-81.
55. 54. Fan S-T, Edgington TS. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest 1991;87:50-7.
56. 55. Lo SK, Gheung A, Zheng Q, Silverstein RL. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 1995;154:4768-77.
57. 56. Heras M, Chesebro JH, Webster MWI, et al. Hirudin, heparin and placebo during deep arterial injury in the pig: the in vivo role of thrombin in platelet-mediated thrombosis. Circulation 1990;82:1476-84.
58. 57. Sassower MA, Abela GS, Kock JM, et al. Angioscopic evaluation of periprocedural and postprocedural abrupt closure after percutaneous coronary angioplasty. Am Heart J 1993;126:444-50.
59. 58. Annex BH, Denning SM, Channon KM, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995;91:619-22.
60. 59. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.